0 Ask Account
Ask

Progesterone in Women with Recurrent Miscarriages

Phil C Boyle, Joseph B Stanford, Paul A Carpentier

Author affiliations (3)
  • NeoFertility Clinic, Suite 7, 1st Floor, Beacon Mall, Sandyford, Dublin 18, Ireland. Phil.Boyle@NeoFertility.ie. ROR
  • University of Utah ROR
  • Mount Wachusett Community College ROR

The New England Journal of Medicine, 374(9), 894, 2016

DOI 10.1056/NEJMc1600491 PMID 26962922

Abstract

No abstract available for this article.

Topics

Pregnancy > Pregnancy Loss > Progesterone TreatmentReproductive Endocrinology > Progesterone > Recurrent MiscarriageRRM Methods > Progesterone Supplementation > Pregnancy Support
progesterone supplementation recurrent miscarriage treatment, Stanford Boyle progesterone recurrent pregnancy loss, luteal phase progesterone support recurrent miscarriage, recurrent miscarriage progesterone therapy evidence commentary, progesterone women recurrent miscarriages NEJM, Carpentier Stanford Boyle progesterone recurrent miscarriage, progesterone deficiency recurrent pregnancy loss treatment, natural progesterone recurrent spontaneous abortion, restorative reproductive medicine progesterone miscarriage prevention, luteal phase defect progesterone supplementation pregnancy outcome
PMID 26962922 26962922 DOI 10.1056/NEJMc1600491 10.1056/NEJMc1600491

Cite this article

Carpentier, P. A., Stanford, J. B., & Boyle, P. C. (2016). Progesterone in Women with Recurrent Miscarriages. *The New England Journal of Medicine*, *374*(9), 894. https://doi.org/10.1056/NEJMc1600491

Keywords

Abortion, Habitual/prevention & Control, Female, Humans, Pregnancy, Progesterone/therapeutic Use, Progesterone

Related articles

Endometriosis. Reply
Becker CM et al., 2020 The New England journal of medicine
Endometriosis > Pathophysiology > Disease MechanismsEndometriosis > Diagnosis > Clinical Review

Contemporary Hormonal Contraception and the Risk of Breast Cancer
Mørch LS et al., 2017 The New England Journal of Medicine

BACKGROUND: Little is known about whether contemporary hormonal contraception is associated with an increased risk of breast cancer. METHODS: We assessed associations between the use of hormonal cont...

Contraception/Comparison > Side Effects > Breast Cancer RiskContraception/Comparison > Hormonal Contraception > Combined Oral ContraceptivesContraception/Comparison > Hormonal Contraception > Progestin-Only Methods

Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
Rolnik DL et al., 2017 The New England Journal of Medicine

BACKGROUND: Preterm preeclampsia is an important cause of maternal and perinatal death and complications. It is uncertain whether the intake of low-dose aspirin during pregnancy reduces the risk of pr...

Pregnancy > Complications > Preeclampsia PreventionPregnancy > Pharmacotherapy > Aspirin ProphylaxisResearch Methodology > Clinical Trials > Randomized Controlled Trial

Oil-Based or Water-Based Contrast for Hysterosalpingography in Infertile Women
Dreyer K et al., 2017 The New England Journal of Medicine

BACKGROUND: Pregnancy rates among infertile women have been reported to increase after hysterosalpingography, but it is unclear whether the type of contrast medium used (oil-based or water-soluble con...

Infertility > Diagnostics > HysterosalpingographyInfertility > Treatment > Tubal FlushingResearch Methodology > Clinical Trials > Randomized Controlled Trial